Synbiotech and Lonza Announce Exclusive Partnership of Development and Sales of Sport Probiotics TWK10(R) for Nutrition Markets in EU and US

Food and Healthcare Press Releases Wednesday September 23, 2020 08:55
KAOSHIUNG--23 Sep--PRNewswire/InfoQuest

Synbiotech and Lonza announce an exclusive collaboration agreement on Lactobacillus plantarum TWK10(R) under which Lonza will exclusively commercialize the innovative probiotic TWK10(R) in the US, Canada, Europe and Brazil whilst at the same time both companies will collaborate to further develop and optimize TWK10(R) and explore new markets and applications.

Synbiotech and Lonza Announce Exclusive Partnership of Development and Sales of Sport Probiotics TWK10(R) for Nutrition Markets in EU and US

Founded in Switzerland in 1897, Lonza is a leading global partner to the pharmaceutical, biotech and specialty ingredients markets, and is one of the leading CDMO (Contract Development and Manufacturing Organization) groups in the globe. Dr. Thomas Kiy, Vice President Strategy and Portfolio Development of Lonza commented, "We have defined Sports Nutrition & Active Living as one of our strategic growth areas and Synbiotech's innovative TWK10(R) probiotic is a perfect complementation of our portfolio in this market. We are excited to launch the first of it's kind sport probiotic product in North America and Europe very soon."

Lactobacillus plantarum TWK10(R), extracted from Taiwanese Kimchi, is a research achievement with collaboration between Synbiotech and academics. Study[1] has shown that it can increase muscle endurance, improve body composition and exercise performance and reduce fatigue. Currently two human clinical papers have been published with US and Taiwan patents obtained. Moreover, TWK10(R) achieved US Self-affirmed GRAS on 29 May 2020, and it becomes the first certified raw material of lactic acid bacteria in local Taiwan.

Dr. San Land Young, human healthcare global operation head of Synbiotech commented, "EU and Japan were leading the global probiotic markets for years, while now the sport probiotics TWK10(R) from Taiwan has attracted attention during its research and development period. Since the clinical trial was reported on Nutrients Scientific Magazine, it has been published dozens of times on international seminars and aroused more attention in scientific community. Lonza expressed its interest on TWK10(R) on European international probiotics seminar early 2019, two companies then started more than one year negotiation and eventually defined the collaboration direction, which has set a significant milestone to the internationalization of Taiwan's probiotic industry."

Mr. Kuie-ming Lee, Vice President of Human Healthcare of Synbiotech said, "Local-developed TWK10(R) is one of the most remarkable sports probiotics in global market. Synbiotech and Lonza will leverage their respective strength on scientific research and market operation, and jointly explore TWK10(R)'s sports nutrition market in EU and US under the principle of win-win and mutual development. On top of cooperation with Lonza Group, Synbiotech is seeking any kind of cooperation that could expand the market for TWK10(R) and will be gradually deploying its international network during 2020-2021, and we are convinced that TWK10(R) probiotic products will be launched soon throughout the major global markets in EU, North America, Southeast Asia, Japan, Korea and China."

[1]Effect of Lactobacillus Plantarum TWK10 on Exercise Physiological Adaptation, Performance, and Body Composition in Healthy Humans. Nutrients 2019. 11(11), 2019, 2836.
Media Contact:
Lisa Chen
Photo -
Caption: Synbiotech and Lonza Announce Exclusive Partnership of Development and Sales of Sport Probiotics TWK10(R) for Nutrition Markets in EU and US

Latest Press Release

Emirates Group rolls out COVID-19 vaccination programme

The Emirates Group recently rolled out a COVID-19 vaccination programme for its substantial UAE based workforce in coordination with the Dubai Health Authority and the Ministry of Health and Prevention. The inoculation drive began in early January 2021,...

Occlutech's Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation for Heart Failure (HF)

Occlutech, a privately-held company, announced today that the U.S Food and Drug Administration (FDA) has granted the Company a Breakthrough Device designation for its first-in-class, implantable Atrial Flow Regulator (AFR) for heart failure (HF) patients...

Nature's Sensation shares tips of how to drink cranberry juice for being healthy all year long

New Year is a very good start for people to begin something new and make a change in their life, but due to the spread of Covid-19, selfcare seems to be the first priority that should not be ignored. To promote well-being, the best practices surely must...

Prudential Launches New Research that Underscores Critical Role of Technology in Improving Healthcare in Asia

88% of Thai respondents are using digital technologies to manage their personal health. This number is the highest across the ASEAN nations surveyed81% of respondents across Asia say technology has improved their access to health services71% of...

New report from FDI World Dental Federation tackles oral health inequalities and outlines strategies to improve oral healthcare over the next ten years

- Oral conditions such as tooth decay, gum disease, tooth loss and oral cancer are the most widespread noncommunicable diseases worldwide - impacting 3.5 billion people - and have severe and significant health, societal, and economic impacts. - Oral...

Related Topics